Answers are grounded in this paper and cite their sources.
Oncolytic viruses (OVs) do more than simply infect and kill host cells. The accepted mechanism of action for OVs consists of a primary lytic phase and a subsequent antitumor and antiviral immune response. However, not all cells are subject to the direct effects of OV therapy, and it is becoming clear that OVs can also impact uninfected cells in the periphery. This review discusses the effects of OVs on uninfected neighboring cells, so-called bystander effects, and implications for OV therapies alone or in combination with other standard of care chemotherapy.
No takes yet. Share an insight, caveat, or question.
Sprague et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: